Department of Thoracic Surgery, Tazuke Kofukai Medical Research Institute, Kitano Hospital, 2-4-20 Ohgimachi, Kita-Ku, Osaka, 530-8480, Japan.
Gen Thorac Cardiovasc Surg. 2024 Nov;72(11):732-737. doi: 10.1007/s11748-024-02034-w. Epub 2024 Apr 27.
Thoracoscopic sympathectomy is an effective treatment for palmar hyperhidrosis. However, compensatory hyperhidrosis occurs frequently as a postoperative complication of the procedure. The goal of this study was to elucidate the clinical significance of thoracoscopic sympathectomy using our surgical procedure.
Consecutive 151 patients who underwent thoracoscopic sympathectomy for palmar hyperhidrosis were studied. In addition, to investigate patients' satisfaction and long-term quality of life, 111 patients were asked to complete a mailing questionnaire survey, and 84 responded (response rate of 75.7%).
All of the 151 patients reported a reduction in palmar sweating during the immediate postoperative period. None of the patients had pneumothorax, hemothorax, Horner's syndrome, or worsening of bradycardia. Based on the questionnaire, the surgical success rate was 98.8%. None of the patients had a recurrence of palmar hyperhidrosis during the long-term postoperative period. However, compensatory hyperhidrosis was reported in 82 patients (97.6%). In total, 94.0% of patients had high levels of postoperative satisfaction.
Thoracoscopic sympathectomy is an effective surgical treatment for palmar hyperhidrosis. By contrast, the careful preoperative explanation of compensatory hyperhidrosis is considered to be very important.
胸腔镜交感神经切除术是治疗手掌多汗症的有效方法。然而，作为该手术的术后并发症，代偿性多汗症经常发生。本研究旨在阐明我们手术方法胸腔镜交感神经切除术的临床意义。
对 151 例因手掌多汗症行胸腔镜交感神经切除术的患者进行了研究。此外，为了调查患者的满意度和长期生活质量，我们对 111 例患者进行了邮寄问卷调查，其中 84 例患者做出了回应（回应率为 75.7%）。
所有 151 例患者在术后即刻均报告手掌出汗减少。所有患者均未出现气胸、血胸、霍纳综合征或心动过缓加重。根据问卷调查，手术成功率为 98.8%。所有患者在长期术后均无手掌多汗症复发。然而，82 例患者（97.6%）报告出现代偿性多汗症。总的来说，94.0%的患者对术后满意度较高。
胸腔镜交感神经切除术是治疗手掌多汗症的有效手术方法。相比之下，仔细解释代偿性多汗症是非常重要的。
